Science Corporation, the neural engineering and brain-computer interface (BCI) company, today announced the European ...

Customized microperimetry helped researchers track geographic atrophy in patients undergoing CTx001 gene therapy, according ...

ASP7317 may offer potential to improve vision and repair retina, not just slow down atroph ...

Science Corp's Prima retina implant restores some sight and has won EU approval, the first US brain-implant device to reach ordinary patients.

Geographic atrophy (GA) is an advanced dry form of age-related macular degeneration (AMD). Up to 20% of folks with AMD may get it. While we see GA across all populations and races, it’s more common in ...

Inflammasome Therapeutics' K8 slowed GA lesion growth 54% and showed a 4.0-letter vision advantage at six months in Phase 2. Phase 3 planned.

Goldberg, MD, MBA, discusses results from a phase 1b study of ASP7317, a human stem cell-derived retinal pigment epithelium ...

A novel outcome measure for geographic atrophy, the Geographic Atrophy Weighted-by-Acuity Index, aligned with best-corrected visual acuity, showing better correlation and predictive accuracy than the ...

This eye condition is a late-stage form of age-related macular degeneration, which is a leading cause of blindness in Americans 65 or older. If you or a loved one has been diagnosed with GA, it can ...

Ryan Haumschild, PharmD, MS, MBA, opens a discussion surrounding the disease landscape of geographic atrophy. Ryan Haumschild, PharmD, MS, MBA: Hello, and welcome to this AJMC® Peer Exchange®program ...

While age and genetics are major unchangeable risk factors for geographic atrophy (GA), adopting healthy habits can help manage the risk. Smoking is strongly linked to increased risk and faster ...